Souparno Ghosh

Souparno Ghosh

Auto-generated profile, based on publicly available information

Souparno Ghosh

Department of Mathematics and Statistics, Texas Tech University, Lubbock, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Natural Hazards Review
Verified
Journal Article
Closed access
ANAli Nejat
Ali Nejat
SGSouparno Ghosh
Souparno Ghosh
Understanding the recovery phase of the disaster cycle is still in its infancy. A thorough grasp of recovery can lead to effective postdisaster planning, which is essential for enabling communities to recover quickly from natural and human-made catastrophes. Recent major disasters such as Hurricanes Sandy and Katrina have revealed the inability of existing policies and planning to promptly restore infrastructure, residential properties, and commercial activities in affected communities. While many studies examined the macroeconomic effects of certain policies on overall recovery, very few, if any, have focused on modeling the housing recovery decisions of households and their contributions to the community’s recovery. The reestablishment of housing is a crucial parameter in understanding recovery processes because it has a ripple effect on the overall timing of recovery. The objective of this study is to create a model capable of predicting postdisaster housing recovery decisions founded on the da...

21 March 2018 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
KMKevin Matlock
Kevin Matlock
CNCarlos De Niz
Carlos De Niz
RRRaziur Rahman
Raziur Rahman
SGSouparno Ghosh
Souparno Ghosh
RPRanadip Pal
Ranadip Pal
A significant problem in precision medicine is the prediction of drug sensitivity for individual cancer cell lines. Predictive models such as Random Forests have shown promising performance while predicting from individual genomic features such as gene expressions. However, accessibility of various other forms of data types including information on multiple tested drugs necessitates the examination of designing predictive models incorporating the various data types. We explore the predictive performance of model stacking and the effect of stacking on the predictive bias and squared error. In addition we discuss the analytical underpinnings supporting the advantages of stacking in reducing squared error and inherent bias of random forests in prediction of outliers. The framework is tested on a setup including gene expression, drug target, physical properties and drug response information for a set of drugs and cell lines. The performance of individual and stacked models are compared. We note that stacking models built on two heterogeneous datasets provide superior performance to stacking different models built on the same dataset. It is also noted that stacking provides a noticeable reduction in the bias of our predictors when the dominant eigenvalue of the principle axis of variation in the residuals is significantly higher than the remaining eigenvalues.

28 December 2018 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
SDSaugato Rahman Dhruba
Saugato Rahman Dhruba
RRRaziur Rahman
Raziur Rahman
KMKevin Matlock
Kevin Matlock
SGSouparno Ghosh
Souparno Ghosh
RPRanadip Pal
Ranadip Pal
In precision medicine, scarcity of suitable biological data often hinders the design of an appropriate predictive model. In this regard, large scale pharmacogenomics studies, like CCLE and GDSC hold the promise to mitigate the issue. However, one cannot directly employ data from multiple sources together due to the existing distribution shift in data. One way to solve this problem is to utilize the transfer learning methodologies tailored to fit in this specific context. In this paper, we present two novel approaches for incorporating information from a secondary database for improving the prediction in a target database. The first approach is based on latent variable cost optimization and the second approach considers polynomial mapping between the two databases. Utilizing CCLE and GDSC databases, we illustrate that the proposed approaches accomplish a better prediction of drug sensitivities for different scenarios as compared to the existing approaches. We have compared the performance of the proposed predictive models with database-specific individual models as well as existing transfer learning approaches. We note that our proposed approaches exhibit superior performance compared to the abovementioned alternative techniques for predicting sensitivity for different anti-cancer compounds, particularly the nonlinear mapping model shows the best overall performance.

21 June 2021 in Engineering, Construction and Architectural Management
Verified
Journal Article
Closed access
SAShihunegn Alemayehu
Shihunegn Alemayehu
ANAli Nejat
Ali Nejat
TGTewodros T Ghebrab
Tewodros T Ghebrab
SGSouparno Ghosh
Souparno Ghosh
Purpose: Building information modeling (BIM) is a process of creating an intelligent virtual model integrating project data from design to construction and operation. BIM models enhance the process of communicating the progress of construction to stakeholders and facilitate integrated project delivery, coordination and clash detection. However, barriers within the construction industry in Ethiopia has led to slow BIM adoption in the country. The aim of this paper is to identify perceived BIM barriers, provide a platform to quantify their importance and develop a regression model to link individual's personal/professional attributes to their perception of BIM barrier.Design/methodology/approach: To address the objectives of this research, an online survey was developed to collect feedback from construction professionals in Ethiopia on 20 major adoption barriers extracted from a thorough review of literature. Relative importance index and strength of consensus metric were employed to identify the significance of barriers. This was then succeeded by performing exploratory factor analysis to determine the major constructs of BIM barriers which was then used to develop a multivariate regression model linking respondents' personal attributes to their perception of BIM barrier.Findings: Results revealed the importance of project complexity and BIM maturity level in prioritizing barriers that are more relevant under various contexts. More specifically, results indicated the following study highlights: Project complexity led to higher perceived weights for lack of appropriate physical/cloud infrastructures, and a BIM standard. Higher levels of BIM maturity signified the importance of BIM internal issues such as liability, licensing and maintenance issues among other adoption barriers. Female participants tended not to consider intangibility of BIM benefits as a major barrier towards BIM adoption compared to male participants. Age of the participants turned out to be the least important factor in their prioritization of BIM perceived adoption barriers.Originality/value: While many research studies have explored BIM adoption barriers in various countries around the world, none to the best of the authors' knowledge have attempted to develop a model to highlight the impact of individuals' personal/professional attributes on their perception of adoption barriers within their community which can help with prioritizing the barriers that are deemed to be more important given the characteristics of the community under study. Our result indicated the importance of BIM maturity level and project complexity in prioritizing barriers associated with BIM adoption within Ethiopia's construction industry.

17 June 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
NBNoah E. Berlow
Noah E. Berlow
RRRishi Rikhi
Rishi Rikhi
MGMathew Geltzeiler
Mathew Geltzeiler
JAJinu Abraham
Jinu Abraham
MSMatthew Svalina
Matthew Svalina
CKCharles Keller
Charles Keller
Cancer patients with advanced disease routinely exhaust available clinical regimens and lack actionable genomic medicine results, leaving a large patient population without effective treatments options when their disease inevitably progresses. To address the unmet clinical need for evidence-based therapy assignment when standard clinical approaches have failed, we have developed a probabilistic computational modeling approach which integrates molecular sequencing data with functional assay data to develop patient-specific combination cancer treatments. Tissue taken from a murine model of alveolar rhabdomyosarcoma was used to perform single agent drug screening and DNA/RNA sequencing experiments; results integrated via our computational modeling approach identified a synergistic personalized two-drug combination. Cells derived from the primary murine tumor were allografted into mouse models and used to validate the personalized two-drug combination. Computational modeling of single agent drug screening and RNA sequencing of multiple heterogenous sites from a single patient’s epithelioid sarcoma identified a personalized two-drug combination effective across all tumor regions. The heterogeneity-consensus combination was validated in a xenograft model derived from the patient’s primary tumor. Cell cultures derived from human and canine undifferentiated pleomorphic sarcoma were assayed by drug screen; computational modeling identified a resistance-abrogating two-drug combination common to both cell cultures. This combination was validated in vitro via a cell regrowth assay. Our computational modeling approach addresses three major challenges in personalized cancer therapy: synergistic drug combination predictions (validated in vitro and in vivo in a genetically engineered murine cancer model), identification of unifying therapeutic targets to overcome intra-tumor heterogeneity (validated in vivo in a human cancer xenograft), and mitigation of cancer cell resistance and rewiring mechanisms (validated in vitro in a human and canine cancer model). These proof-of-concept studies support the use of an integrative functional approach to personalized combination therapy prediction for the population of high-risk cancer patients lacking viable clinical options and without actionable DNA sequencing-based therapy.

18 December 2017 in Bioinformatics
Verified
Journal Article
Closed access
PDF file
JMJoshua Mayer
Joshua Mayer
RRRaziur Rahman
Raziur Rahman
SGSouparno Ghosh
Souparno Ghosh
RPRanadip Pal
Ranadip Pal
Motivation: Random forest (RF) has become a widely popular prediction generating mechanism. Its strength lies in its flexibility, interpretability and ability to handle large number of features, typically larger than the sample size. However, this methodology is of limited use if one wishes to identify statistically significant features. Several ranking schemes are available that provide information on the relative importance of the features, but there is a paucity of general inferential mechanism, particularly in a multi-variate set up. We use the conditional inference tree framework to generate a RF where features are deleted sequentially based on explicit hypothesis testing. The resulting sequential algorithm offers an inferentially justifiable, but model-free, variable selection procedure. Significant features are then used to generate predictive RF. An added advantage of our methodology is that both variable selection and prediction are based on conditional inference framework and hence are coherent.Results: We illustrate the performance of our Sequential Multi-Response Feature Selection approach through simulation studies and finally apply this methodology on Genomics of Drug Sensitivity for Cancer dataset to identify genetic characteristics that significantly impact drug sensitivities. Significant set of predictors obtained from our method are further validated from biological perspective.Availability and implementation: https://github.com/jomayer/SMuRFSupplementary information: Supplementary data are available at Bioinformatics online.